Estimaciones de analistas de Wall Street para Kamada Ltd. (KMDA): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-09 | $0.14 | ||
| 2026-08-12 | $0.16 | $0.11 | +42.2% |
| 2026-05-13 | $0.07 | $0.12 | -41.7% |
| 2026-03-11 | $0.06 | $0.09 | -33.3% |
| 2025-11-10 | $0.09 | $0.10 | -10.0% |
| 2025-08-13 | $0.13 | $0.09 | +44.4% |
| 2025-05-14 | $0.07 | $0.07 | +0.0% |
| 2025-03-05 | $0.07 | $0.05 | +40.0% |
Ratios de valoración
| Ratio P/E | 20.76 |
| Precio / Valor contable | 1.71 |
| EV / EBITDA | 10.97 |
| Rentabilidad por dividendo | 5.28% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $77.5M | $102.8M | $114.5M | $127.2M | $133.2M | $103.6M | $129.3M | $142.5M | $161.0M | $180.5M |
| Coste de Ventas | $55.8M | $70.7M | $73.0M | $77.5M | $85.7M | $73.3M | $82.6M | $87.0M | $91.0M | $104.1M |
| Beneficio Bruto | $21.6M | $32.1M | $41.5M | $49.7M | $47.6M | $30.3M | $46.7M | $55.5M | $70.0M | $76.4M |
| I+D | $16.2M | $12.0M | $9.7M | $13.1M | $13.6M | $11.4M | $13.2M | $13.9M | $15.2M | $13.0M |
| Generales y Administrativos | $10.9M | $12.7M | $12.2M | $12.8M | $14.7M | $17.6M | $25.1M | $27.4M | $30.8M | $33.8M |
| Gastos Operativos | $27.1M | $24.6M | $22.2M | $27.0M | $28.3M | $31.0M | $42.2M | $45.4M | $49.9M | $50.2M |
| Beneficio Operativo | -$5.8M | $7.4M | $19.3M | $22.8M | $19.2M | -$696000 | $4.5M | $10.1M | $20.1M | $26.2M |
| EBITDA | -$2.0M | $11.2M | $23.5M | $27.8M | $25.4M | $4.0M | $10.8M | $21.2M | $27.8M | $39.2M |
| Gastos por Intereses | $126000 | $82000 | $327126 | $293000 | $266000 | $283000 | $914000 | $1.3M | $660000 | $864000 |
| Beneficio Antes de Impuestos | -$5.0M | $7.2M | $20.3M | $23.0M | $18.6M | -$1.9M | -$2.3M | $8.4M | $13.3M | $23.5M |
| Impuestos | $1.7M | $269000 | -$2.0M | $730000 | $1.4M | $345000 | $62000 | $145000 | -$1.1M | $3.3M |
| Beneficio Neto | -$6.7M | $6.9M | $22.3M | $22.3M | $17.1M | -$2.2M | -$2.3M | $8.3M | $14.5M | $20.2M |
| BPA | $-0.18 | $0.18 | $0.55 | $0.57 | $0.42 | $-0.05 | $-0.05 | $0.17 | $0.25 | $0.38 |
| BPA Diluido | $-0.18 | $0.18 | $0.55 | $0.57 | $0.41 | $-0.05 | $-0.05 | $0.15 | $0.25 | $0.37 |
| Acciones en Circulación (Diluidas) | $36.4M | $38.0M | $40.5M | $40.6M | $44.6M | $44.8M | $44.8M | $53.7M | $57.8M | $58.3M |
Precio
| Precio | $8.19 |
| Capitalización | $473M |
| Bolsa | NASDAQ |
| País | IL |
Empresas relacionadas: AUNA · EOLS · GALT · PRTC · QSI · RCKT · SLDB
Explorar sector: Healthcare · Drug Manufacturers - Specialty & Generic
Más secciones de KMDA: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones